Associated Papers
Structural insight into a novel human CCR5-V130I variant associated with resistance to HIV-1 infection.
Stambouli N et al.
Journal of Biomolecular Structure & Dynamics, 2014
Structural basis for the interaction of CCR5 with a small molecule, functionally selective CCR5 agonist.
Saita Y et al.
Journal of Immunology (baltimore, Md. : 1950), 2006
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors.
Billick E et al.
Journal of Virology, 2004
CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.
Lin G et al.
Journal of Virology, 2001
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
Siciliano SJ et al.
The Journal of Biological Chemistry, 1999
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
Kuhmann SE et al.
Journal of Virology, 1997
Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus.
Palacios E et al.
Current Biology : Cb, 0
Select a paper to view details